Tag: Repairon

Repairon Announces Positive Clinical Outcomes of Engineered Heart Muscle as Reparative Therapy for Advanced Heart Failure Reported at the Scientific Sessions of the American Heart Association

Coronary/Structural Heart by 0 comments

NEW ORLEANS, Nov. 11, 2025 /PRNewswire/ — Yesterday at the Ernest N Morial Convention Center, latest clinical trial findings were disclosed on the use of human engineered heart muscle as biological ventricular assist tissue (BioVAT) transplants in patients with advanced heart failure….

Continue Reading →

Groundbreaking Therapy for Advanced Heart Failure: Repairon Completes Series A Financing to Expand the Clinical Development of Its Regenerative Heart Therapy

Financial by 0 comments

GÖTTINGEN, Germany, Oct. 2, 2025 /PRNewswire/ — German biotech company Repairon GmbH announced the completion of a Series A round of financing that will enable further clinical development of its groundbreaking regenerative heart failure therapy. The therapy repairs cardiac function and…

Continue Reading →

Repairon Announces Completion of Dose-Finding Part of BioVAT-HF Phase 1/2 Trial in Advanced Heart Failure

Coronary/Structural Heart by 0 comments

Feasibility and safety demonstrated in patients with advanced heart failure Safe maximal dose for continuation into Phase 2 (Proof-of-Concept) identified Proof for successful heart remuscularization obtained Interim data on 15 patients with 800 million cells dose expected in Q2 2024 GÖTTINGEN, Germany, April 04, 2023 (GLOBE NEWSWIRE) — Repairon, a […]

Continue Reading →